EMD Serono has partnered the Trump administration to expand access to the company’s in vitro fertilisation (IVF) therapies.

France-based Adcytherix has completed a Series A funding round, raising €105m ($122m) earmarked for expediting the ADC ...

The AAM’s Giuseppe Randazzo warns that the generics business could become unsustainable in the future if the market dynamics ...

"Meanwhile, Goldman Sachs led by value but faced close competition from JP Morgan. The investment banks had their own notable ...

With a legacy rooted in global scientific excellence, Sweden is quietly building one of Europe’s most dynamic biotech ...

Novo Nordisk will now run a Phase III trial for Omeros' former lead asset, zaltenibart in rare blood disorder, PNH.

While established US biotech hubs may still rule the roost, emerging competitors are looking to grab a larger slice of the ...

A consortium led by Nordic Capital and Permira has raised its bid, though certain shareholder stances remain firm.

AstraZeneca has unveiled a newly expanded manufacturing facility in Texas to the tune of $445m, as the drugmaker aims to meet ...

Oceanpine Capital is to acquire an 80% equity stake in Beijing Jacoray Pharmaceutical Technology for 200m yuan ($28m).

BioCryst Pharmaceuticals has signed a definitive agreement to buy Astria Therapeutics with a mix of cash and stock ...

The WHO calls for increased policy focus on neurological disorders like Alzheimer’s disease, an indication that has seen ...